Zobrazeno 1 - 10
of 339
pro vyhledávání: ''
Publikováno v:
Cerebrovascular Diseases. 50:162-170
Background: While endovascular stroke treatment (EST) of large vessel occlusions in acute ischemic stroke (AIS) is proven to be safe and effective, there are subgroups of patients with increased rates of hemorrhages. Our goal was to identify risk fac
Autor:
Sameer Bakhshi, Mehar Chand Sharma, Ankit Gupta, Seema Sharma, Kalpana Kumari, Umesh Velu, Ahitagni Biswas
Publikováno v:
Pediatric Neurosurgery. 56:184-196
Introduction: Spinal atypical teratoid/rhabdoid tumour (AT/RT) is exquisitely rare and constitutes 2% of all AT/RTs. Case Presentation: A 6-year-old boy presented with low backache for the last 5 months. MRI of the spine showed a 1.5 × 1.5 × 4.7 cm
Autor:
Richard J. Barohn, Mazen M. Dimachkie, Mohammed H. Alanazy, Nadeem Shafique Butt, Ahmad R. Abuzinadah
Publikováno v:
Eur Neurol
Objective: The aim of the study was to estimate the exacerbation incidence rate (IR) in acetylcholine receptor antibody (AChR)-positive generalized myasthenia gravis (MG) and its predictors. Methods: The primary outcome in this retrospective study wa
Autor:
Alan T. Davis, Laurel M. Packard, Yao Cheng, Jiangyong Min, Fnu Rameez, Justin Singer, Muhib Khan, Nabil Wees, Philip McCarthy, Nadeem Khan
Publikováno v:
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra, Vol 10, Iss 3, Pp 159-165 (2020)
Cerebrovascular Diseases Extra, Vol 10, Iss 3, Pp 159-165 (2020)
Objective: Our study aims to evaluate the impact of a stay-at-home order on stroke metrics during the 2019-novel coronavirus (COVID-19) pandemic. Methods: Data on baseline characteristics, stroke subtype, initial National Institutes of Health Stroke
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 3, Pp 148-158 (2020)
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra
Introduction: The delipid extracorporeal lipoprotein filter from plasma (DELP) has been approved for the treatment of acute ischemic stroke (AIS) by the China Food and Drug Administration, but its effectiveness and mechanism are not yet fully determi
Autor:
Beyhan Ceylaner Bicakci, Fatih Demircioglu, Cengiz Gemici, Naciye Isik, Melike Pekyurek, Gokhan Yaprak, Necati Tatarlı
Publikováno v:
Stereotactic and Functional Neurosurgery. 98:167-175
Background: Glioblastoma (GBM) is a dismal disease. Recurrence is inevitable despite initial surgery and postoperative temozolomide (TMZ) and radiotherapy. Salvage surgery is the standard treatment in selected patients. Chemotherapy, biological agent
Autor:
René Hurlemann, Oliver Kaut, Tamara Schaprian, Thomas Klockgether, Marcus Grobe-Einsler, Ina R. Vogt
Publikováno v:
Neurodegenerative diseases 20(2-3), 104-109 (2020). doi:10.1159/000510057
Background: Rivastigmine is an acetylcholine esterase inhibitor which is commonly used as therapy for dementia in Alzheimer’s disease and Parkinson’s disease (PD). Recently, a randomized controlled trial demonstrated a positive effect of rivastig
Autor:
Jeffrey Hatef, Giorgio Veneziano, David P. Martin, Tarun Bhalla, Jeffrey R. Leonard, Luke G F Smith
Publikováno v:
Pediatric Neurosurgery. 55:181-187
Introduction: Selective dorsal rhizotomy (SDR) provides lasting relief of spasticity for children suffering from cerebral palsy, although controlling postoperative pain is challenging. Postoperatively, escalation of therapies to include a patient-con
Autor:
Masakatsu Nishikawa, Akira Ogawa, Shinsuke Nanto, Kazunori Toyoda, Yasuo Ikeda, Takanari Kitazono, Kenji Abe, Kazuo Kitagawa
Publikováno v:
Cerebrovasc Dis
Introduction: The safety of prasugrel in elderly and/or low body weight Japanese patients with ischemic stroke who have a relatively high bleeding risk with antiplatelet therapy remains unknown. Objective: We aimed to investigate the safety and effic
Autor:
Liyuan Zhou, Qixiong Qin, Haihong Li, Ya Chen, Yunfei Wei, Xuemei Quan, Jing Wei, Zhijian Liang, Shengyu Li, Qingqing Yang, Guohui Li, Dacheng Wang
Publikováno v:
European Neurology. 83:41-48
Background: The occurrence of ischemic stroke in patients with non-Hodgkin lymphoma (NHL) is not well understood. This study aimed to determine independent risk factors to identity ischemic stroke in non-Hodgkin lymphoma-associated ischemic stroke (N